Illumina

Associate Director, Value Evidence Strategy (Remote)

United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Genomics, HealthcareIndustries

Requirements

A Bachelor's degree is required, with an advanced degree (GC, MBA, MPH, PhD, or related) being preferred. Candidates must have 15 years of experience, including over 7 years in management within a clinical setting, market access, reimbursement, and/or health economics, with a significant focus on molecular diagnostics. Proven success in developing market access strategies and partnerships in the diagnostics, biopharma, or payer sectors is essential, along with a solid understanding of reimbursement systems, HTA processes, and payer decision-making across major global markets. Experience with molecular diagnostics and next-generation sequencing is also required.

Responsibilities

The Associate Director will support global market access strategies for molecular diagnostic solutions, including client and ecosystem partnerships, and internal development processes. They will collaborate with regional and country teams to secure reimbursement and access in key markets, addressing diverse payer requirements and Health Technology Assessment processes. Responsibilities include partnering with Government Affairs, Commercial, Medical Affairs, and Marketing teams to support strategies for gaining, protecting, and expanding access to genomic solutions. The role involves defining and communicating the clinical and economic value of diagnostics through compelling value propositions, evidence generation studies, and payer engagement. They will also support the Global Health Economics and Outcomes Team on evidence generation strategies, monitor global policy coverage trends, aid in the development of global value dossiers and reimbursement toolkits, and build relationships with external stakeholders like payers and HTA bodies. Additionally, the position requires maintaining positive working relationships with customers, distributors, and core laboratories, supporting Commercial and Marketing engagements, and providing strategic input into product development, launch planning, and lifecycle management, while ensuring compliance with all relevant standards.

Skills

Value Evidence Strategy
Market Access
Molecular Diagnostics
Oncology
Genetic Disease
Reproductive Health
Genomic Technology
Reimbursement
Health Technology Assessment
Government Affairs
Commercial Strategy
Medical Affairs
Marketing

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI